Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010

Pediatric Research - Tập 74 Số S1 - Trang 35-49 - 2013
Hannah Blencowe1, Joy E. Lawn2, Thomas Vazquez3, Alistair R. Fielder4, Clare Gilbert5
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
2Centre for Maternal Reproductive & Child Health, London School of Hygiene and Tropical Medicine, London, UK
3North Middlesex University Hospital, London, UK
4Department of Ophthalmology, City University, London, UK
5Department of Clinical Research, International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pascolini D, Mariotti SP . Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–8.

Hoyt CS, Jan JE . How to help the visually disabled child and family. Pediatric Ophthalmology and Strabismus. 4th edn. Chap. 59. Hoyt CS, Taylor D, eds. Edinburgh, UK: Elsevier Saunders, 2013.

O’Connor A, Fielder AR . Long term ophthalmic sequelae of prematurity. Early Hum Dev 2008;84:101–6.

Good WV, Hardy RJ, Dobson V, et al.; Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15–23.

Lee J, Dammann O . Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med 2012;17:26–9.

Ng YK, Fielder AR, Shaw DE, Levene MI . Epidemiology of retinopathy of prematurity. Lancet 1988;2:1235–8.

Hartnett ME, Penn JS . Mechanisms and management of retinopathy of prematurity. N Engl J Med 2012;367:2515–26.

Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628–40.

Cross KW . Cost of preventing retrolental fibroplasia? Lancet 1973;2:954–6.

Stenson BJ, Orme JA . The twists and turns of neonatal oxygen therapy. Early Hum Dev 2012;88:961–3.

EURO-PERISTAT project 2006. European Perinatal Health Report, 2004.

Darlow BA, Hutchinson JL, Simpson JM, Henderson-Smart DJ, Donoghue DA, Evans NJ . Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network. Br J Ophthalmol 2005;89:1592–6.

Gilbert CE, Canovas R, Kocksch de Canovas R, Foster A . Causes of blindness and severe visual impairment in children in Chile. Dev Med Child Neurol 1994;36:326–33.

Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A . Retinopathy of prematurity in middle-income countries. Lancet 1997;350:12–4.

Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, et al. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol 2011;95:1502–5.

Limburg H, Gilbert C, Hon do N, Dung NC, Hoang TH . Prevalence and causes of blindness in children in Vietnam. Ophthalmology 2012;119:355–61.

Gilbert C . Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77–82.

Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–96.

Blencowe H, Vos T, Lee AC et al. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. Pediatr Res 2013 (this issue).

United Nations Population Division 2010. “World Population Prospects.” ( http://esa.un.org/unpd/wpp/index.htm .) Accessed 9 October 2012.

Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162–72.

Rouse DJ . Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomized controlled trial - commentary. Obstet Gynecol Surv 2006;61:691–3.

Holmström GE, Hellström A, Jakobsson PG, Lundgren P, Tornqvist K, Wallin A . Swedish national register for retinopathy of prematurity (SWEDROP) and the evaluation of screening in Sweden. Arch Ophthalmol 2012;130:1418–24.

Gilbert C, Fielder A, Gordillo L, et al.; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005;115:e518–25.

Shah PK, Narendran V, Kalpana N, Gilbert C . Severe retinopathy of prematurity in big babies in India: history repeating itself? Indian J Pediatr 2009;76:801–4.

Shrestha S, Dangol SS, Shrestha M, Shrestha RP . Outcome of preterm babies and associated risk factors in a hospital. JNMA J Nepal Med Assoc 2010;50:286–90.

Good WV, Hardy RJ, Dobson V et al. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010;128:663–71.

Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 1996;114:417–24.

Fielder AR . The natural ocular outcome of premature birth and retinopathy: status at 1 year. Arch Ophthalmol 1995;113:850–1.

Blencowe H, Lee AC, Cousens S et al. Preterm birth–associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr Res 2013 (this issue).

Moore T, Hennessy EM, Myles J et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012;345:e7961.

Hakeem AH, Mohamed GB, Othman MF . Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol 2012;19:289–94.

Fielder AR, Levene MI . Screening for retinopathy of prematurity. Arch Dis Child 1992;67(7 Spec No):860–7.

Sathiamohanraj SR, Shah PK, Senthilkumar D, Narendran V, Kalpana N . Awareness of retinopathy of prematurity among pediatricians in a tier two city of South India. Oman J Ophthalmol 2011;4:77–80.

Chen Y, Li X . Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic? Br J Ophthalmol 2006;90:268–71.

Seroczynska M, Gralek M, Kanigowska K . Analysis of the changes in the causes of blindness and significant vision loss among children and young adults born between 1974 and 2004. Med Wieku Rozwoj 2007;11(2 Pt 2):193–216.

Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–94.

Gunn DJ, Cartwright DW, Gole GA . Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol 2012;40:93–9.

Axer-Siegel R, Maharshak I, Snir M, et al. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina (Philadelphia, PA) 2008;28:839–46.

Jalali S, Kesarwani S, Hussain A . Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2. Am J Ophthalmol 2011;151:719–724.e2.

Husain SM, Sinha AK, Bunce C, et al. Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity. J Pediatr 2013;163:67–72.

Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1997;115:604–8.

Sabri K, Manktelow B, Anwar S, Field D, Woodruff G . Ethnic variations in the incidence and outcome of severe retinopathy of prematurity. Can J Ophthalmol 2007;42:727–30.

Lad EM, Nguyen TC, Morton JM, Moshfeghi DM . Retinopathy of prematurity in the United States. Br J Ophthalmol 2008;92:320–5.

Roberts D, Dalziel S . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006:CD004454.

Doyle KJ, Bradshaw WT . Sixty golden minutes. Neonatal Netw 2012;31:289–94.

Stenson BJ, Tarnow-Mordi WO, Darlow BA et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013;368:2094–2104.

Carlo WA, Goudar SS, Jehan I, et al.; First Breath Study Group. Newborn-care training and perinatal mortality in developing countries. N Engl J Med 2010;362:614–23.

Schmidt B, Whyte RK, Asztalos EV, et al.; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013;309:2111–20.

Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W ; NeOProM Collaborative Group. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 2011;11:6.

Zin AA, Moreira ME, Bunce C, Darlow BA, Gilbert CE . Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics 2010;126:e410–7.

Varughese S, Gilbert C, Pieper C, Cook C . Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes. Br J Ophthalmol 2008;92:879–82.

Gordillo L, Villanueva AM, Quinn GE . A practical method for reducing blindness due to retinopathy of prematurity in a developing country. J Perinat Med 2012;40:577–82.

Wilson CM, Ells AL, Fielder AR . The challenge of screening for retinopathy of prematurity. Clin Perinatol 2013;40:241–59.

Gupta V, Whelan KF, Schneider L, et al. National variations in retinopathy of prematurity screening criteria in Canada: existent guidelines and actual practice patterns. Can J Ophthalmol 2012;47:473–8.

Jalali S, Matalia J, Hussain A, Anand R . Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries. Am J Ophthalmol 2006;141:966–8.

Sun X, Lemyre B, Barrowman N, O’Connor M . Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review. Acta Paediatr 2010;99:329–34.

Wu C, Vanderveen DK, Hellström A, Löfqvist C, Smith LE . Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol 2010;128:443–7.

Darlow BA, Gilbert CE, Quiroga AM . Setting up and improving retinopathy of prematurity programs: interaction of neonatology, nursing, and ophthalmology. Clin Perinatol 2013;40:215–27.

Haines L, Fielder AR, Scrivener R, Wilkinson AR ; Royal College of Paediatrics and Child Health, the Royal College of Ophthalmologists and British Association of Perinatal Medicine. Retinopathy of prematurity in the UK I: the organisation of services for screening and treatment. Eye (Lond) 2002;16:33–8.

Moral-Pumarega MT, Caserío-Carbonero S, De-La-Cruz-Bértolo J, Tejada-Palacios P, Lora-Pablos D, Pallás-Alonso CR . Pain and stress assessment after retinopathy of prematurity screening examination: indirect ophthalmoscopy versus digital retinal imaging. BMC Pediatr 2012;12:132.

Chiang MF, Gelman R, Martinez-Perez ME, et al. Image analysis for retinopathy of prematurity diagnosis. J AAPOS 2009;13:438–45.

Skalet AH, Quinn GE, Ying GS, et al. Telemedicine screening for retinopathy of prematurity in developing countries using digital retinal images: a feasibility project. J AAPOS 2008;12:252–8.

Wilson CM, Wong K, Ng J, Cocker KD, Ells AL, Fielder AR . Digital image analysis in retinopathy of prematurity: a comparison of vessel selection methods. J AAPOS 2012;16:223–8.

Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE . Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2013;98:F170–4.

USAID 2013. Investing in Prevention: Childhood Blindness. Washington, DC: USAID.

USAID 2007. The USAID Child Blindness Program: Fostering Development Through the Prevention and Treatment of Blinding Eye Disease. Washington, DC: USAID.

Holmström G, Larsson E . Long-term follow-up of visual functions in prematurely born children–a prospective population-based study up to 10 years of age. J AAPOS 2008;12:157–62.

O’Connor AR, Stephenson TJ, Johnson A, Tobin MJ, Ratib S, Fielder AR . Change of refractive state and eye size in children of birth weight less than 1701 g. Br J Ophthalmol 2006;90:456–60.

O’Connor AR, Stephenson TJ, Johnson A, Tobin MJ, Ratib S, Fielder AR . Strabismus in children of birth weight less than 1701 g. Arch Ophthalmol 2002;120:767–73.

Holmström G, el Azazi M, Kugelberg U . Ophthalmological follow up of preterm infants: a population based, prospective study of visual acuity and strabismus. Br J Ophthalmol 1999;83:143–50.

VanderVeen DK, Bremer DL, Fellows RR, et al.; Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS 2011;15:536–40.

Robaei D, Rose KA, Kifley A, Cosstick M, Ip JM, Mitchell P . Factors associated with childhood strabismus: findings from a population-based study. Ophthalmology 2006;113:1146–53.

Larsson E, Rydberg A, Holmström G . Contrast sensitivity in 10 year old preterm and full term children: a population based study. Br J Ophthalmol 2006;90:87–90.

Harvey EM, Dobson V, Luna B, Scher MS . Grating acuity and visual-field development in children with intraventricular hemorrhage. Dev Med Child Neurol 1997;39:305–12.

Dobson V, Quinn GE, Abramov I, et al. Color vision measured with pseudoisochromatic plates at five-and-a-half years in eyes of children from the CRYO-ROP study. Invest Ophthalmol Vis Sci 1996;37:2467–74.

Geldof CJ, van Wassenaer AG, de Kieviet JF, Kok JH, Oosterlaan J . Visual perception and visual-motor integration in very preterm and/or very low birth weight children: a meta-analysis. Res Dev Disabil 2012;33:726–36.

Robaei D, Kifley A, Gole GA, Mitchell P . The impact of modest prematurity on visual function at age 6 years: findings from a population-based study. Arch Ophthalmol 2006;124:871–7.

The International Classification of Retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991–9.

Shah PK, Narendran V, Kalpana N . Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed 2012;97:F371–5.

Reynolds JD, Dobson V, Quinn GE, et al.; CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002;120:1470–6.

Austeng D, Källen KB, Hellström A, Tornqvist K, Holmström GE . Natural history of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch Ophthalmol 2010;128:1289–94.

Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1993;111:339–44.

Webber AL, Wood J . Amblyopia: prevalence, natural history, functional effects and treatment. Clin Exp Optom 2005;88:365–75.